Option chain shows key data for Numinus Wellness's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Numinus Wellness.

Numinus Wellness (OTC:NUMIF) Stock, Option Chain

Numinus Wellness Inc develops proprietary, psychedelic-centered, therapeutic products and services through its laboratory and research & development processes. The company's clinic network consists of Numinus Health, Mindspace Services, and the Neurology Center of Toronto. Its services include Ketamine-assisted psychotherapy for depression, neurological care, psychotherapy, and counseling by registered psychologists among others. The company's operating segments are; Clinical research operations, Canadian clinic network, US clinic network and Corporate. The majority of the revenue for the company is generated from US clinic network segment. Geographically, the company has its presence in United States and Canada.

Cannabis

News

Psychedelics

NUMIF

Numinus Wellness sells U.S. clinics to Stella for $3.5M, in a partnership to develop tech-driven solutions for mental health providers.

Numinus Wellness Sells US Clinics, Partners With Stella For Tech-Driven Mental Health Solutions

Regulations

Health Care

ATAI

CMPS

MBIO

AWAKNF

MDMA Therapy For PTSD Faces FDA Delay: Are There Other Ways Forward?

finance and psychedelics (anaterate, sergeitokmakov by Pixabay)(3)

Earnings

CSE:MBAI

TSX:NUMI

Psychedelics-focused mental health care company Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF), announced on Thursday its third quarter financial results for the three months ended May 31, 2024.&#34;In the third quarter of 2024, we continued to make progress on our program to transition Numinus to an operationally lean company prepared to benefit from the anticipated growth in psychedelic therapy. Key to the program is achieving profitability with our existing operations and leveraging our significant experience and expertise to opportunities in the broad market,&#34; Payton Nyquvest, Numinus founder and CEO, said.

Psychedelics Co. Numinus Narrows Loss In Q3, Reports QoQ Decrease In Revenue, Gross Profit

NUMINUS WELLNESS INC by Numinus Wellness Inc.

Numinus Wellness Inc

Small Cap

Press Releases

Numinus Applies for Management Cease Trade Order

Numinus Provides Bi-Weekly Update on Annual Filings

Insurance

Numinus Wellness Closes Sale of Clinics and Launches Initiative to Increase Access to Mental Health Care

Numinus Wellness Announces Corporate Update

Numinus Wellness Announces Cease Trade Order and Provides Corporate Update

Numinus Wellness Inc. Announces Strategic Wind-Down of Non-Operating Subsidiaries

Numinus Wellness Inc. Announces CFO Transition

Numinus Approved as a State-Certified Natural Medicine Training Program in Colorado

Numinus Wellness

Comments

Numinus Wellness

Numinus Wellness (NUMIF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga